Merck, CBL479, Anti-Integrin β3 Antibody, clone PM6/13

Immunogen
Human platelet plasma membrane
Application
FACS: As a marker for megakaryoblastic/cytic leukaemias and idiopathic thrombocythemia

Optimal working dilutions must be determined by the end user.
Research Category
Cell Structure
Research Sub Category
Integrins
This Anti-Integrin β3 Antibody, clone PM6/13 is validated for use in FC, IP, WB, IH, IH(P) for the detection of Integrin β3.
Biochem/physiol Actions
The antibody is specific for the 110 kDa platelet glycoprotein GP IIIa and inhibits platelet aggregation and activation induced by thrombin and collagen. The platelet glycoprotein is the integrin beta3 chain of the vitronectin receptor and GPIIb/IIIa. The antigen is present on platelets and megakaryocytes.

Antigen distribution:

Platelets >98%

Megakaryocytes >98%

Granulocytes 0%

Monocytes 0%

LGL cells 0%

B cells 0%

T cells 0%

Peripheral blood lymphocytes 0%

FUSION PARTNER: SP2/0 myeloma cell line
Physical form
Format: Purified
The monoclonal is presented at a concentration of 100μg/1ml in phosphate buffered saline containing 10mM sodium azide and 1mg/ml bovine serum albumin. We recommend that each laboratory determine an optimum working titre for use in its particular application.
Preparation Note
For use within 1 month of purchase store at +4°C, for long term storage aliquot antibody into small volumes and store at -20°C.
Other Notes
Replaces: MAB1381
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.